Identification | Back Directory | [Name]
(βR,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid | [CAS]
651770-09-1 | [Synonyms]
Atorvastatin calcium impurity B02 (3R,5S)-Atorvastatin EP Impurity B (single configuration) Calcium salt (βR,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (βR,δS)- | [Molecular Formula]
C33H35FN2O5 | [MOL File]
651770-09-1.mol | [Molecular Weight]
558.64 |
Hazard Information | Back Directory | [Uses]
(βR,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid is an intermediate in the synthesis of (3R,5S)-Atorvastatin Sodium Salt (A791725), which is an Atorvastatin impurity in bulk drug and tablets. |
|
|